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Abstract
Background: Organ site-specific metastasis is an ominous feature for most poor-prognostic hepatocellular
carcinoma (HCC) patients. Cancer cell lines and animal models are indispensable for investigating the molecular
mechanisms of organ specific tropism. However, till now, little is known about the drivers in HCC metastatic
tropism, and also no effective way has been developed to block the process of tropistic metastasis.
Methods: In this study, we established several monoclonal HCC cell lines from HCCLM3-RFP together with their
xenograft models, and then analyzed their metastatic potentials and tropisms using in-vitro and in-vivo assays, and
finally elucidated the driving forces of HCC tropistic metastases.
Results: Six monoclonal cell lines with different organ site-specific tropism were established successfully. SPARC,
VCAM1 and ANGPTL4 were found positively correlated with the potentials of lung metastasis, while ITGA1 had a
positive relation to lymph node metastasis of enterocoelia.
Conclusions: By our powerful platforms, HCC metastatic tropisms in clinic could be easily mimicked and
recapitulated for exploring the bilateral interactions between tumor and its microenvironment, elucidating the
drivers of HCC metastatic tropisms, and testing anti-cancer effects of newly developed agent in pre-clinical stage.
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Background
Hepatocellular carcinoma (HCC) is the third common
cause of cancer death worldwide [1]. Tumor metastasis to
distant vital organs is responsible for more than 90 %
HCC-related fatalities although the metastatic process is
claimed to be an inefficient on [2, 3]. In the process, the
vast majority of circulating tumor cells is incapable of
progressive metastasis growth at distant organs [4, 5].
Furthermore, tumor metastasis often exhibit organ-site
specific tropism, preferring to grow in certain organ [6, 7].
For example, HCC is more likely to metastasize to lung,
lymph node and adrenal gland, but less frequently to bone
and brain. Although the phenomena have been observed
for several decades in clinic, their molecular bases on HCC
metastatic tropism are still poorly understood.
Tumor metastasis is a multiple complex process which
is driven by an accumulation of genetic mutations and
detuning expression, making a few tumor cells an acqui-
sition of a full ability of organ-site specific metastasis
during its evolutional process [8]. Based on our previous
knowledge, it is easy to understand that the community
of cancer cells is a collection of heterozygosis [9]. In fact,
several established breast cancer and prostate cancer cell
lines with bone and/or lymph node metastatic tropisms
support the idea of cancerous heterogeneity. Up to now,
however, no such cell lines and animal models are
available for studying the metastatic tropisms of HCC.
Little is known about the drivers in HCC metastatic
tropism, and also no effective way has been developed to
block the process of tropistic metastasis. Therefore, it is
desperately needed to develop several monoclonal HCC
cell lines with different organ-site tropisms to identify
the underlying mechanisms of this phenotype.
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In the past decade, researchers from Liver Cancer
Institute of Fudan University have successfully estab-
lished two human HCC xenografts in nude mice, namely
LCI-D20 and LCI-D35, via orthotopic transplantation of
tumor tissues from HCC patients, and then successfully
cloned several HCC cell lines with different metastatic
potentials from LCI-D20 xenografts, such as MHCC97,
HCCLM3 and HCCLM6 [10–12]. More recently, our
group developed a red fluorescent protein-expressing
HCC cell line, HCCLM3-RFP (HCCLM3-R), whose
xenograft models in nude mice can provide a real-time
observation of tumor growth and metastasis [13–15]. In
this study, we intended to establish several monoclonal
HCC cell lines from HCCLM3-RFP, and then analyze its
metastatic potentials and tropisms, and finally elucidate
the driving forces of HCC tropistic metastases.
Methods
Animals
Male BALB/c nu/nu mice with 4-6 weeks old were
obtained from the Shanghai Institute of Materia Medica,
Chinese Academy of Science (CAS), China, and housed
in laminar-flow cabinets under specific pathogen-free
conditions. The mice were kept for 5-7 days as an adap-
tation period before being subjected to experimental use.
The study protocol on mice was approved by the Shanghai
Medical Experimental Animal Care Committee. All ani-
mals received humane care according to the criteria out-
lined in the "Guide for the Care and Use of Laboratory
Animals" prepared by the National Academy of Sciences
and published by the National Institutes of Health (NIH
publication 86-23 revised 1985).
Cell culture
HCCLM3 was established by Dr. Li et al. in our institute
[11]. HCCLM3-R with high metastatic potential, used as
parental cell line in the study, was maintained in high-
glucose Dulbecco’s modified eagle medium (D-MEM;
GibcoBRL, Grand Island, NY) supplemented with 10 %
fetal bovine serum (GibcoBRL, Grand Island, NY) in a
humidified atmosphere of 5 % CO2 at 37 °C.
Human ethics
Human ethics approval was not required for any aspect
of this study.
Establishment of HCCLM3-RFP xenograft models
Male athymic BALB/c nude mice with 4 weeks old (Insti-
tute of Materia, CAS, Shanghai, China) were injected each
with 1 × 107 HCCLM3-R cells in 200 μl 0.9 % sodium
chloride solution on the right upper flank region to estab-
lish subcutaneous xenograft model. When it reached 1 cm
in diameter 3 or 4 weeks later, the subcutaneous tumor
was removed, cut into pieces in a size of 2 × 2 × 2 mm3
and implanted into the livers of another 8 nude mice, as
described previously [11].
Colonization of single-cell derived HCC population
By virtue of RFP signaling, metastatic tissues were biop-
sied directly from the lung and lymph node of orthotropic
HCCLM3-R xenograft models. The first descendant cells
from lung and lymph node metastatic foci, namely LM-1
and LnM-1 respectively, were trypsinized, washed with
PBS, and resuspended at 1000 cells/ml. The suspensions
were serially diluted in 10-fold volume of fresh media.
One hundreds μl of such diluted suspension was added
into the well of 96-well plate. After 24 h, these wells har-
boring a single cell were identified and labeled under
microscope. Two weeks later, only colonies derived from
one single cell were trypsinized and sub-cultured gradually
using a 12-well plate, 6-well plate, and then a 15 cm tissue
flask.
Metastatic tropism of monoclonal HCC cells
Each monoclonal HCC cell line was used to establish
xenograft models in 6 nude mice. On the 6th week after
orthotopic transplantation, all animals were sacrificed
for autopsy. Spontaneous metastasis to liver, lung and
celiac lymph nodes were imaged under stereomicroscope
(Leica, Heerbrugg, Switzerland). The integrated optical
density (IOD) of the tumor fluorescence was quantitated
by Image Pro Plus software 6.0 (Media Cybernetics,
Bethesda, MD). And the metastatic tropism of each
monoclonal HCC cell line was plotted using IOD.
Pathological examination
Orthotopic tumor and its metastatic foci were resected for
histopathological studies. After fixed with 4 % formalde-
hyde, lung metastasis tissue were embedded in paraffin and
serially cut for hemotoxylin and eosin staining. Tumor
metastatic potential in each monoclonal HCC xenograft
was analyzed by the following semi-quantitative scoring
system as described by Dr. Gao [16], which is advantage to
evaluate tumor metastatic potential, even when the meta-
static foci in a given organ are overlapped into a cluster. In
detail, Grade I: the diameter of metastatic foci in lung were
less than 0.5 mm; Grade II: the diameter of foci was
between 0.5 and 1 mm; Grade III: the diameter of foci was
between 1 and 2 mm; Grade IV: the diameter of foci was
more than 2 mm. For a large metastatic tumor, the number
of foci was multiple of grade IV. Then, the total metastatic
foci number of each monoclonal HCC cell line = grade I ×
1+ grade II × 2+ grade III × 3+ grade IV × 4.
Lung colonization assays
A tail vein injection model was employed for lung
colonization assays [16]. In brief, nude mice were injected
with 1 × 105 of viable parent and monoclonal HCC cells via
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a lateral tail vein. Three days later, the lungs were removed
for making continuous frozen section. The colonized foci
of HCCLM3-R and its derived monoclonal cells in lung
were quantified by fluorescence microscope.
Cell proliferation assays
Cell proliferation was determined by the Cell Counting
Kit-8 assay (Dojin Laboratories, Kumamoto, Japan). In
brief, HCCLM3-R and its derived monoclonal cells in
exponential growth phase were trypsinized to give single-
cell suspension. Then the cell concentration was adjusted
into 2 × 104 /ml, and added 100 μl of cell suspension into
each well of a 96-well plate. After a cell culture of 0-, 24-,
48-, 72- and 96-h at 37 °C with 5 % of CO2, 10 μl of the
kit reagent was added to each well. Two hours later, all
plates were scanned by a microplate reader (Thermo
Fisher Scientific, Waltham, MA) at 450 nm. Cell prolifera-
tion was calculated on the basis of absorbency.
Migration and invasion assays
Cell migration and invasion was analyzed by a Transwell™
Permeable Supports system (Corning, Corning, NY) ac-
cording to the manufacturer’s instruction. HCCLM3-R
and its derived monoclonal cells were seeded into un-
coated upper insert at 5 × 104 cells for migration assay and
seeded into a Matrigel (BD Biosciences, San Jose, CA)
coated upper insert at 1 × 105 cells for invasion assay.
Then, the medium containing 10 % fetal bovine serum as
a chemoattractant was added into the lower well. Follow-
ing a culture of 24 or 48 h, non-invading cells were
removed from the upper surface by wiping with a cotton
swab. The membrane was fixed with 4 % formaldehyde
for 15 min at room temperature. The invading cells were
stained with Giemsa (Sigma, St Louis, MO) for 25 min,
and its numbers in ten fields of each triplicate filter were
analyzed by inverted microscope.
RNA extraction and real-time PCR
Total RNA was purified using TRIzol Reagent (Invitrogen
Life Technologies, Carlsbad, CA) following the manufac-
turer’s instruction. The quality of RNA was examined by
A260 absorption. And 500 ng of total RNA was reversely
transcribed into first-strand cDNA using PrimeScript RT
reagent kit (Takara, Tokyo, Japan). Real-time PCR in tripli-
cate was performed on a DNA Engine Opticon system
(MJ Research, Reno, NV) using SYBR Premix Ex Taq
(TaKaRa, Tokyo, Japan). And the reaction was evaluated
with the Opticon Monitor software (Version 1.02). The
primer sequences for interested mRNAs were synthesized
by Sangon Biotech (Sangon Biotech, Shanghai, China;
Additional file 1: Table S1). The threshold cycle (Ct)
values were analyzed using the comparative Ct (ΔΔCt)
method as previously reported [17]. The level of target
mRNA was obtained by normalizing to the endogenous
reference and relative to a control.
Western blot analysis
Total cell protein was extracted from HCCLM3-R and its
derived monoclonal cells with ProteoJETTM Mammalian
Cell Lysis Reagent (Fermentas, Waltham, MA), supple-
mented with phenylmethanesulfonyl fluoride (PMSF;
Roche, Indianapolis, IN). Equal protein amount was loaded
onto 10 % SDS-PAGE gels. The protein samples were sepa-
rated and transferred onto PVDF membranes (Millipore,
Billerica, MA) for 2.5 h at 110 V. After blocked with 5 %
milk solution in TBS for 1 h at room temperature, the
membrane was incubated with rabbit antibodies against
VCAM1 (1:1000, Epitomics, Burlingame, CA), SPARC
(1:1000, Epitomics, Burlingame, CA), ANGPTL4 (1:1000,
Abgent, San Diego, CA) and ITGA1 (1:1000, Abgent, San
Diego, CA) overnight at 4 °C respectively. Membranes
were washed extensively and then incubated for 1 h with
anti-rabbit IgG conjugated to HRP (1:5000). The protein
bands were visualized using enhanced chemiluminescence
reagents (Thermo Fisher Scientific, Waltham, MA),
acquired by Molecular Imager ChemiDox XRS + Imaging
System (Bio-Rad Laboratories, Hercules, CA) and quanti-
fied with Gel-Pro Analyzer (United Bio, Sanborn, NY).
Immunohistochemistry assays
Immunohistochemistry for target molecules was per-
formed on single serial section made from primary
tumor samples. The slides probed with a primary
antibody against VCAM1 (1:200, Epitomics, Burlin-
game, CA), SPARC (1:200, Epitomics, Burlingame,
CA), ANGPTL4 (1:100, Abgent, San Diego, CA) and
ITGA1 (1:100, Abgent, San Diego, CA), and then in-
cubated with HRP (horseradish peroxidase) -conju-
gated IgG (1:500, Invitrogen) and the proteins in situ
were visualized with 3, 3’-diaminobenzidine. Density of
target proteins was determined as previous report [18].
Statistical analysis
All values are expressed as mean ± standard deviation.
Data were analyzed by the computer program Graphpad
Prism 5 software [16]. The number of lung metastasis in
histopathological examinations, were shown by median.
Quantitative variables were analyzed by One-way
ANOVA, Kruskal-Wallis test or Fisher exact test to com-
pare the qualitative variables. Other comparisons were
performed by using unpaired 2-sided Student’s t test
without equal variance assumption or nonparametric
Mann-Whitney test. Results were considered statistically
significant at p < 0.05.
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Results
First descendent cell lines from HCCLM3-R with organ
tropism
As shown in Fig. 1a and c, metastatic tissues with RFP
signaling were biopsied directly from lung and lymph
node of orthotropic HCCLM3-R xenograft models. The
first descendant cells from lung and lymph node meta-
static foci were named LM-1 and LnM-1, respectively.
The lineages of HCCLM3-R and its derived clones were
examined by exon sequencing. And a similar LOH ex-
pression pattern was found in these 3 cells lines, indicat-
ing that the derived 2 clones came from the same
parental cell line (data unshown). To investigate the
organ-specific tropisms of these two cell lines, subcuta-
neous and orthotropic xenograft models were built in
nude mice. Indeed, LM-1 xenografts, during a 6-weeks
observation, apparently displayed more lung metastatic
capabilities than lymph node (Fig. 1b). As anticipated,
Fig. 1 Schematical diagrams of LM-1 and LnM-1 establishments and their metastatic tropisms. a & c Establishing approaches of LM-1 and LnM-1 cells
from HCCLM3-R xenograft models. b & d Representative images of HCC metastatic patterns in LM-1 and LnM-1 orthotropic xenograft models (left).
Quantitative analyses of HCC metastases in lung and lymph node with foci number as well as fluorescence area (right). Data are presented as mean
± SEM, Wilcoxon rank testing was used
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LnM-1 showed significantly metastatic tropism to lymph
node than lung metastases (Fig. 1d). A district metastatic
propensity curves was obtained between LM-1 and
LnM-1 cell lines (Fig. 1b and d). Therefore, the capaci-
ties of organ-specific metastasis were able to be inher-
ited in its descendent cells.
Metastatic tropism of single cell–derived populations
from HCCLM3-R
In order to establish monoclonal HCC cell lines with
organ specific metastatic potentials, a total of 155 single-
cell wells were obtained by limiting dilution of LM1 and
LnM1 cells (Fig. 2a). Among them, only 13 subclones
grew well in vitro system. All of them displayed an
epithelioid, polygonal-shaped morphology, which were
similar to their parental cell line, HCCLM3-R. Six of
thirteen (6/13) monoclones, named LM1-S3, LM1-S4,
LM1-S5, LM1-S11, LnM1-S11 and LnM1-S13, were suc-
cessfully established subcutaneous and then orthotopic
xenograft models. The representative metastatic patterns
of these 6 monoclones were imaged by fluorescence
microscope (Fig. 2b), quantified by IOD assay and
pathological examination after a 6-weeks implantation
(Fig. 2b). Our results showed once more that distinct
metastatic abilities of 6 monoclonal cell lines were dis-
played in both of metastatic inclination and metastatic
potential. Lung metastatic tropisms were found in LM1-
S3, LM1-S4, LM1-S5 and LM1-S11 derived xenograft
models, And, LM1-S4 had the highest potential of lung
metastasis among these monoclonal cell lines (p <0.01;
Table 1). More interesting, LnM1-S11 exhibited dual
organ metastatic potentials, both to lung and celiac lymph
nodes (p < 0.05; Table 2). In our histopathological exami-
nations, the median of lung metastases (Q2) in LM1-S3,
LM1-S4, LM1-S5, LM1-S11, LnM1-S11 and LnM1-S13
xenograft models were 102 (Q1 = 99, Q3 = 121), 1426 (Q1
= 1230, Q3 = 1655), 70 (Q1 = 59, Q3 = 85), 621 (Q1 = 588,
Q3 = 694), 564 (Q1 = 535, Q3 = 611) and 477 (Q1 = 420,
Q3 = 526) respectively. These results were further con-
firmed by IOD quantitative study (Table 2).
Lung colonization of monoclonal HCC cell lines
Colonization and outgrowth at a distant site are the key
final step in the process of metastatic cascade and, more
importantly, colonization is the basis of organ specific
metastasis. To test the relationship between colonizing
ability and lung metastatic potential, the monoclonal cells
were injected into the nude mice via tail vein. The
dynamic changes of HCC cells in lung were observed
using fluorescent signal in this tumor models. Shortly after
injection, many HCC cells were non-specifically
trapped in the lung, and then tumor cells were dra-
matically attenuated within the first few days due to
blood perfusion and tumor apoptosis. At 72 h after
injection, a significant difference in lung colonization
of these monoclonal HCC cells was monitored
(Fig. 2c). As expected, LM1-S4 exhibited the highest
lung colonizing ability in all tested cells including its
parental cells (p <0.001; Fig. 2c). Moreover, LnM1-S11
had the second highest capability of lung colonization
in all tested cells (p <0.001; Fig. 2c).
Proliferation, migration and invasion abilities of
monoclonal HCC cells
The capabilities of tumor proliferation, migration and
invasion are the basic important features to complete a
whole process of tumor metastasis. Therefore, we com-
pared cell proliferation of each monoclonal HCC cells to
its parental cells in parallel. During a 7-days’ observation,
LM1-S4 grew the fastest (p <0.0001) and LnM1-S11 grew
the second fastest of all tested HCC cell lines (p <0.01;
Fig. 3a). No significant differences in cell proliferation
were found between LM1, LnM1, LM1-S3, LM1-S5, LM1-
S11 and LM1-S13 cells.
Next, we assessed the migration and invasion abil-
ities of these monoclonal HCC cell lines. First, we in-
vestigated the migration capability in LM1-S4, LM1-
S11, LM1, and HCCLM3-R. The results showed that
LM1-S4 had highest abilities of motility in all tested
cell lines (p <0.0001; Fig. 3b). And LnM1-S11 exhib-
ited stronger capabilities of migration than other cell
lines, except of LM1-S4 (p <0.0001; Fig. 3b). Next, we
investigated the invasion capability in LM1-S4, LM1-
S11, LM1, and HCCLM3-R. The results showed that
invasion capabilities of LM1-S4 and LnM1-S11 were
much higher than other cell lines (p <0.0001; Fig. 3c).
Collectively, our findings suggest that the metastatic
potentials of these monoclonal cell lines were remark-
ably different.
Tropism-related genes in HCC metastasis
More and more evidences indicated that tumor metastatic
potential and tropism were regulated by different panel of
genes. To identify the key drivers of HCC metastatic tro-
pisms, we first reviewed several recently published articles
and selected 30 candidates which had been found to regu-
late tumor metastatic tropisms in breast, prostate and lung
cancer, etc [19–25] (Additional file 1: Table S1). Then, the
expression levels of these genes were analyzed by real-
time PCR and only 21 genes were successfully detected
in our subclonal cells (Additional file 2: Table S2 and
Additional file 3: Figure S1). Four differentially
expressed genes, named SPARC, ANGPTL4, VCAM1
and ITGA1, were finally picked out because their
mRNA levels were more than 1.5-fold up-regulated in
over half of monoclonal cell lines as compared with
their parental cells (Fig. 4a). To validate above results,
the corresponding proteins were detected again by
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Western blots in these monoclonal cell lines. Indeed,
the protein levels of SPARC, ANGPTL4 and VCAM1
were remarkably correlated with the potentials of lung
metastasis, while ITGA1 was positively related to celiac
lymph node metastasis (p < 0.01; Fig. 4b). To analyze
protein levels in vivo, tumor tissues from monoclonal
Fig. 2 Metastatic tropisms and lung colonizing abilities of monoclonal HCC cell lines. a Representative images of the screening processes of
monoclonal cell line under bright field (top) and red fluorescence field (bottom, ×100). b Metastatic foci in lung (top, ×1.25) and celiac lymph
node (middle, ×0.63) visualized via fluorescence microscope; lung metastasis (bottom, ×200) verified in H&E-stained sections. c Lung colonies of
monoclonal HCC cells in the recipient mice at 72 h after tail vein injection (left); Quantification of colonizing cells in frozen sections of lung (right).
Data are presented as mean ± SEM, Kruskal-Wallis was used
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HCC xenografts and their parental HCC xenograft were
stained by immunohistochemistry. Once again, SPARC,
ANGPTL4 and VCAM1 were highly expressed in both
LM1-S4 and LnM1-S11 xenograft tissues, while ITGA1
only in LnM1-S11 xenograft tissues (Fig. 5a and b). All
those results indicated that SPARC, ANGPTL4, VCAM1
and ITGA1 might be the key drivers of HCC metastatic
tropisms.
Discussion
Tumor metastasis has been a bottleneck in HCC prog-
nosis and therapy. To elucidate the underlying mecha-
nisms, metastatic human HCC cell lines and their
corresponding xenograft models had been widely used
to mimic the metastatic cascade of HCC in human
being. For the purpose, a serial of human HCC cell lines,
such as MHCC97, HCCLM3 and HCCLM6, with high
metastatic potentials, were successfully established at
Liver Cancer Institute in the past decade [10–12]. To
monitor the real-time process of HCC metastasis
in vivo, HCCLM3-R, a stably RFP expressed cell, was
used for establishment of xenograft model [13]. Taking
the advantage of red fluorescent signaling, multiple
metastatic foci in liver, lung as well as lymph nodes of
posterior peritoneum were easy to be visualized in nude
mice as early as 2 weeks after orthotopic transplant-
ation. The results obviously suggested that HCCLM3-R
is a heterogeneous population with different metastatic
tropisms.
As the heterogeneity of tumor cells would compli-
cate to clarify the issue of HCC metastatic tropism, we
decided to isolate monoclonal cells from HCCLM3-R.
By the virtue of RFP signaling, two direct descendent
HCC cell lines, named LM1 and LnM1, were success-
fully established from lung and lymph node metastatic
foci of HCCLM3-R xenograft. By limiting dilution in
vitro, more monoclonal cell lines, such as, LM1-S3,
LM1-S4 and LM1-S11 were sequentially established
from LM1 cells, and LnM-S11 and LnM-S13 from
LnM1 cells as well. Still, the metastatic potentials and
tropisms of these monoclonal cell lines were remark-
ably different. For example, the former 3 monoclonal
cells had a propensity of lung metastasis, while the lat-
ter 2 cells exhibited dual metastatic tropisms. LM1-S4
showed the highest capability of lung metastasis, and
LnM1-S11 had the highest dual-metastatic capabilities,
both to lung and lymph node. By far, we successfully
established a serial monoclonal HCC cell lines from
one parental cell line in the world. These monoclonal
HCC cell lines, together with their xenograft models
would provide us a powerful tool for HCC tropism
study.
Although there are a lot of hypotheses on tumor me-
tastasis and metastatic tropism, none of them can ex-
plain well on all issues seen in metastatic cascade.
Stephen Paget’s “seed and soil” theory, for example, is
the most famous one where he postulated that metasta-
ses of a particular type of cancer ("the seed") often
metastasizes to certain sites ("the soil") based on the
similarity of the environments of the original and sec-
ondary tumor sites [5, 26]. Until now, the theory is still
widely accepted and further explained by the concept of
Table 2 Metastatic tropisms of monoclonal cell lines gauged by fluorescence area (pixel)
Lung metastasis area Lymph node metastasis area Z value P value
LM1-S3 176820 ± 13120 0 −2.521 0.012
LM1-S4 1296000 ± 524228 0 −2.521 0.012
LM1-S5 34676 ± 7388 0 −2.521 0.012
LM1-S11 499011 ± 133568 0 −2.521 0.012
LnM1-S11 486529 ± 180184 884586 ± 442968 −1.820 0.069
LnM1-S13 41132 ± 23599 21873 ± 4712 −1.820 0.069
χ2 40.71 46.39
P value (Kruskal-Wallis) <0.0001 <0.0001
Pixel represented the fluorescence area. Wilcoxon rank test was used to test the same cell line metastasis variables. Kruskal-Wallis was used to analyze qualitative
variables among these six cell lines
Table 1 Incidence rate of lung and lymph node metastases of
monoclonal HCC cell lines




LM1-S3 8/8 0/8 0.0002
LM1-S4 8/8 0/8 0.0002
LM1-S5 8/8 0/8 0.0002
LM1-S11 6/8 0/8 0.0070
LnM1-S11 8/8 8/8 —
LnM1-S13 2/8 2/8 1.000
Forty-eight nude mice were divided randomly into 6 groups with 8 ones in
each group. Qualitative variables were compared using Fisher's exact test.
Kruskal-Wallis was used to analyze qualitative variables among these six
cell lines
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interplay between the tumor and its microenvironment.
Meanwhile, the theory of Darwinian’s selection is also an
active one, in which only a few clonal tumor cells is
endowed with all abilities to complete the whole cascade
of metastasis [27, 28]. Our observations in this study con-
firmed the right of Darwinian’s selection hypothesis once
more, because only a few of isolated monoclonal HCC
cells were able to successfully grow in vitro and even more
few progressive metastasis in xenograft models. These
preliminary results indicated that HCCLM3 was com-
posed of different subsets with district proliferation, inva-
siveness, and metastatic tropisms.
In these 30 candidates, both mRNA and protein levels
of SPARC, ANGPTL4 and VCAM1 were finally found
significantly up-regulated in most monoclonal HCC cell
lines with lung metastasis potential, especially in LM1-S4,
as compared to their parental cells. And ITGA1 were
mainly increased in LnM-S11, a monoclonal cell with high
Fig. 3 Proliferation, migration and invasion abilities of monoclonal HCC cells. a Cell proliferation curves of monoclonal HCC cells and their
parental cells. b & c Representative images (left) and their statistical results (right) of monoclonal HCC cells using migration and invasion assays
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lymph node tropism. All these results indicated that
SPARC, ANGPTL4 and VCAM1 might be a core panel of
drivers modulating HCC lung metastasis, while ITGA1 is
an important driver regulating HCC lymph node tropism.
Although these observations are similar to the previous
ones in melanoma, and breast cancer, in which SPARC is
required in extracellular matrix synthesis [21]; ANGPTL4
weakens cell-cell conjunctions by initiating integrin α5β1-
mediated RAC/PAK signaling [22]; VCAM1 often alters
cell adhesion as a cell surface sialoglycoprotein [23]; and
ITGA1 mediates cell-collagen or cell-laminin adhesion
[24, 25]. Furthermore, the differential expression levels of
IGTA1, VCAM1, SPARAC and ANGPTL4 in these sub-
clonal cells have been further confirmed in our mRNA
sequencing data (GEO accession: GSE38945). All these
results suggest that IGTA1, VCAM1, SPARAC and
ANGPTL4 could be the drivers of HCC metastatic
tropisms. Although, the gains-of-functions or/and
loss-of-functions of these candidates need be further
explored [29, 30].
Conclusions
In a word, several monoclonal HCC cell lines and their
xenograft models were successfully established from
Fig. 4 Tropism-related genes in HCC metastasis. a The endogenous mRNA levels of ITGA1, VCAM1, SPARC and ANGPTL4 in monoclonal HCC cells
analyzed by Real-time PCR analysis. b The protein levels of ITGA1, VCAM1, SPARC and ANGPTL4 of monoclonal HCC cells quantified by Western
blot. GAPDH was included as loading control. Data are presented as mean ± SEM, One-way ANOVA was used
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HCCLM-R cells in this study. By these powerful in-
vitro and in-vivo platforms, we believed, HCC meta-
static tropisms in clinic could be easily mimicked and
recapitulated for exploring the bilateral interactions
between tumor and its microenvironment, elucidating the
drivers of HCC metastatic tropisms, and testing anti-
cancer effects of newly developed agent in pre-clinical
stage.
Fig. 5 Protein levels of ITGA1, VCAM1, SPARC and ANGPTL4 in xenograft tissues. Representative images (a, ×100) and Quantitative results (b) of
ITGA1, VCAM1, SPARC and ANGPTL4 protein levels in primary xenograft tissues using immunohistochemical staining analyses. Data are presented
as mean ± SEM, One-way ANOVA was used
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Additional file 1: Table S1. Thirty candidate genes whose functions
are related to tropism metastasis of breast, prostate and lung cancer, etc.
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